oxazoles has been researched along with scopolamine hydrobromide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggleton, JP; Aigner, TG; DeLong, MR; Mishkin, M; Mitchell, SJ; Price, DL; Struble, RG; Wenk, GL | 1 |
| Arnt, J; Christensen, AV | 1 |
| Helén, P; London, ED | 1 |
| Harada, M; Hidaka, K; Ichihara, M; Tamura, T; Tsukamoto, S; Usuda, S; Wanibuchi, F | 1 |
| Dearden, JC; Filimonov, D; Galaeva, I; Garibova, TL; Geronikaki, AA; Gloriozova, T; Krajneva, V; Lagunin, A; Macaev, FZ; Molodavkin, G; Pogrebnoi, SI; Poroikov, VV; Shepeli, F; Tsitlakidou, M; Vlad, L; Voronina, TA | 1 |
| Brodney, MA; Davoren, JE; Edgerton, JR; Fortin, JP; Garnsey, M; Grimwood, S; Harris, AR; Jenkinson, S; Kenakin, T; Lazzaro, JT; Lee, CW; Lotarski, SM; Nottebaum, L; O'Neil, SV; Pettersen, B; Popiolek, M; Ramsey, S; Steyn, SJ; Thorn, CA; Webb, D; Zhang, L | 1 |
| Beohar, M; Ganeshpurkar, A; Gutti, G; Kakarla, R; Krishnamurthy, S; Kumar, A; Kumar, D; Singh, SK | 1 |
7 other study(ies) available for oxazoles and scopolamine hydrobromide
| Article | Year |
|---|---|
Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
Topics: Acetylcholinesterase; Animals; Basal Ganglia; Brain Mapping; Choline O-Acetyltransferase; Cholinergic Fibers; Discrimination Learning; Dose-Response Relationship, Drug; Form Perception; Ibotenic Acid; Macaca fascicularis; Oxazoles; Pattern Recognition, Visual; Physostigmine; Receptors, Muscarinic; Scopolamine; Substantia Innominata | 1987 |
Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics.
Topics: Amphetamine; Animals; Antipsychotic Agents; Catalepsy; Humans; Isoxazoles; Male; Oxazoles; Rats; Scopolamine; Stereotyped Behavior | 1981 |
Muscimol-scopolamine interactions in the rat brain: a study with 2-deoxy-D-[1-14C]glucose.
Topics: Animals; Brain; Deoxyglucose; gamma-Aminobutyric Acid; Glucose; Muscimol; Oxazoles; Rats; Rats, Inbred Strains; Scopolamine | 1984 |
Synthesis and structure-activity studies of a series of spirooxazolidine-2,4-diones: 4-oxa analogues of the muscarinic agonist 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dione.
Topics: Amnesia; Animals; Male; Mice; Mice, Inbred ICR; Oxazoles; Parasympathomimetics; Rats; Receptors, Muscarinic; Scopolamine; Structure-Activity Relationship | 1993 |
Design of new cognition enhancers: from computer prediction to synthesis and biological evaluation.
Topics: Amnesia; Animals; Avoidance Learning; Computer Simulation; Drug Design; Male; Nootropic Agents; Oxazoles; Rats; Scopolamine; Thiazoles | 2004 |
Design and Synthesis of γ- and δ-Lactam M
Topics: Allosteric Regulation; Amphetamine; Animals; Ataxia; Diarrhea; Dogs; Donepezil; Drug Design; Female; Humans; Indans; Isoindoles; Lactams; Male; Mice, Inbred C57BL; Microsomes, Liver; Oxazoles; Piperidines; Rats, Wistar; Receptor, Muscarinic M1; Scopolamine; Seizures; Structure-Activity Relationship; Sulfonamides; Thiadiazoles; Vomiting | 2017 |
Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amines; Amnesia; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Eels; Female; Horses; Humans; Ligands; Male; Mice; Molecular Structure; Neuroprotective Agents; Oxazoles; Rats; Rats, Wistar; Scopolamine; Structure-Activity Relationship | 2019 |